Patrick Sullivan

Patrick Sullivan currently serves as the Head of Commercial at Harrow since August 2025. Previously, Patrick held the position of Vice President Marketing for the Neurology Portfolio at Corium from December 2021 to August 2025, where responsibilities included the US commercialization of ADHD and dementia treatments, notably AZSTARYS and ADLARITY. Prior to Corium, Patrick was with AstraZeneca, serving as Global Commercial Head for Renal and Hematology, overseeing the commercialization of Evrenzo and Roxadustat. Patrick's extensive experience spans various roles in leading companies such as Shire Pharmaceuticals, Adolor, Novartis, and Bayer, focusing on market strategies and product launches across multiple therapeutic areas. Patrick holds a Bachelor of Science in Business Administration with a concentration in Marketing from Widener University and is pursuing an Executive MBA in Healthcare Marketing from Saint Joseph's University.